Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoshuan
- Development stage
- Unknown
- Lead developer
- Buchang Pharmaceuticals
- Administration
- Oral
01
Overview
Xiaoshuan is a Traditional Chinese Medicine (TCM) formulation, typically administered as enteric-coated capsules, used primarily for the treatment and recovery of cardiovascular and cerebrovascular diseases. The formula is composed of multiple herbal extracts, including *Astragalus membranaceus* (Huangqi), *Salvia miltiorrhiza* (Danshen), and *Lumbricus* (Dilong), which work synergistically to promote blood circulation, resolve blood stasis, and unblock collaterals. It is widely prescribed in China for the recovery phase of ischemic stroke (cerebral infarction) to improve neurological deficits and prevent recurrent thrombotic events. Recent clinical research, such as trials conducted at the First Affiliated Hospital of Dalian Medical University, has investigated its potential in alleviating fatigue syndrome and improving quality of life in patients following cardiovascular and cerebrovascular accidents.
- Brand names
- Xiaoshuan
- Other names
- Xiaoshuan enteric-coated capsulesXiaoshuan Changrong Jiaonang
02
Targets
Fibrin (Factor Ia)
Beyond the preview
Go deeper on Xiaoshuan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiaoshuan.